StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
2632
This month
78
This week
19
This year
634
Yesterday
4
Publishing Date
2023 - 09 - 26
10
2023 - 09 - 07
8
2023 - 07 - 17
12
2023 - 06 - 05
14
2023 - 05 - 25
10
2023 - 05 - 16
11
2023 - 05 - 09
8
2023 - 04 - 26
10
2023 - 04 - 17
9
2023 - 03 - 28
8
2023 - 02 - 16
8
2022 - 12 - 05
8
2022 - 11 - 03
9
2022 - 09 - 16
9
2022 - 07 - 28
8
2022 - 06 - 22
10
2022 - 06 - 10
9
2022 - 05 - 23
8
2022 - 02 - 25
9
2022 - 02 - 14
9
2021 - 12 - 13
19
2021 - 12 - 09
16
2021 - 12 - 06
8
2021 - 12 - 01
7
2021 - 11 - 30
8
2021 - 11 - 29
12
2021 - 11 - 15
9
2021 - 11 - 12
12
2021 - 11 - 09
7
2021 - 11 - 08
8
2021 - 10 - 25
8
2021 - 10 - 15
9
2021 - 10 - 07
7
2021 - 10 - 04
8
2021 - 09 - 29
7
2021 - 09 - 28
7
2021 - 09 - 27
12
2021 - 09 - 20
13
2021 - 09 - 17
10
2021 - 09 - 16
9
2021 - 09 - 13
12
2021 - 08 - 18
7
2021 - 06 - 29
7
2021 - 06 - 28
8
2021 - 06 - 25
10
2021 - 06 - 22
7
2021 - 06 - 11
9
2021 - 06 - 07
8
2021 - 05 - 24
7
2021 - 05 - 21
15
2021 - 05 - 20
8
2021 - 05 - 19
7
2021 - 05 - 11
7
2021 - 04 - 20
7
2021 - 04 - 13
7
2021 - 04 - 12
8
2021 - 03 - 24
9
2021 - 03 - 15
7
2020 - 12 - 11
7
2020 - 12 - 09
8
Sector
Administrative and support and waste management and remediation services
6
Commercial services
45
Communications
26
Consumer durables
9
Consumer non-durables
26
Consumer services
16
Distribution services
3
Electronic technology
47
Energy minerals
18
Finance
114
Finance and insurance
18
Health care and social assistance
6
Health services
25
Health technology
1679
Industrial services
15
Information
12
Manufacturing
187
Mining, quarrying, and oil and gas extraction
42
Miscellaneous
9
N/a
82
Non-energy minerals
97
Process industries
32
Producer manufacturing
44
Professional, scientific, and technical services
81
Real estate and rental and leasing
3
Retail trade
10
Technology services
74
Transportation
8
Transportation and warehousing
6
Utilities
8
Wholesale trade
1
Tags
Acquisition
7055
Agreement
2209
Application
2155
Approval
2170
Business
2575
Cancer
3702
Ceo
2249
Ces
2918
Collaboration
2133
Conference
20160
Corporation
4409
Covid
2708
Covid-19
1945
Deadline
3483
Disease
2379
Distribution
2745
Drug
2453
Earnings
3438
Energy
6702
Europe
2194
Events
4531
Fda
3054
Financial
10607
Financial results
8251
Global
9194
Group
3975
Growth
11319
Health
4444
Management
2124
Market
19257
Media
2010
Meeting
2621
N/a
244718
Nasdaq
3108
Offering
6621
Partnership
2415
People
2290
Pharma
2104
Pharmaceuticals
2008
Platform
1994
Positive
2632
Presentation
2791
Program
3300
Report
13087
Research
9228
Results
35434
Sales
1978
Services
2435
Solutions
2117
Spac
1950
Study
1963
System
2286
Technology
5597
Test
2281
Therapeutics
7662
Therapy
2648
Treatment
4645
Trial
6334
Update
3729
Year
4439
Entities
Abbvie inc.
27
Adial pharmaceuticals, inc
10
Alnylam pharmaceuticals, inc.
17
Amgen inc.
13
Amryt pharma plc
8
Annovis bio, inc.
8
Aquestive therapeutics, inc.
17
Arrival
17
Artelo biosciences, inc.
8
Astellas pharma inc
11
Astrazeneca plc
11
Beigene, ltd.
18
Beyondspring, inc.
11
Biogen inc.
11
Biontech se
15
Bridgebio pharma, inc.
12
Bristol-myers squibb company
25
Clearside biomedical, inc.
12
Coherus biosciences, inc.
19
Dare bioscience, inc.
9
Eli lilly and company
24
Five prime therapeutics, inc.
9
Fortress biotech, inc.
9
Gartner, inc.
12
Gilead sciences, inc.
12
Glaxosmithkline plc
12
Hoth therapeutics, inc.
13
I-mab
8
Immix biopharma, inc.
10
Immutep limited
10
Incyte corporation
14
Ionis pharmaceuticals, inc.
14
Johnson & johnson
37
Kering
10
Lantern pharma inc.
8
Lithium corp
12
Mediwound ltd.
9
Merck & company, inc.
16
Morgan stanley
9
Morphic holding, inc.
9
Myovant sciences ltd.
10
Nasdaq, inc.
42
Novartis ag
17
Orange
18
Pfizer, inc.
41
Pliant therapeutics, inc.
9
Redhill biopharma ltd.
10
Regeneron pharmaceuticals, inc.
23
Regenxbio inc.
13
Rocket pharmaceuticals, inc.
11
Sanofi
87
Scynexis, inc.
11
Seagen inc.
9
Sorrento therapeutics, inc.
19
Takeda pharmaceutical company limited
12
Taylor devices, inc.
17
Teva pharmaceutical industries ltd
11
Transcode therapeutics inc
8
Veru inc.
10
Yamana gold inc.
8
Symbols
ABBV
27
ADIL
10
ALNY
17
ALPMF
11
ALPMY
11
AMGN
13
AMYT
8
ANVS
8
AQST
17
ARTL
8
ARVL
17
AZN
11
BBIO
12
BGNE
18
BIIB
11
BMY
25
BNTX
15
BYSI
11
CHRS
19
CLSD
12
DARE
9
FBIO
9
FNCTF
18
FPRX
9
GILD
12
GSK
12
HOTH
13
IMMP
10
IMMX
10
INCY
14
IONS
14
IT
12
JNJ
37
LLY
24
LTUM
12
MDWD
9
MORF
9
MRK
16
MS
9
MYOV
10
NDAQ
42
NVS
17
NVSEF
13
PFE
41
PLRX
9
PPRUF
10
PPRUY
10
RCKT
11
RDHL
10
REGN
23
RGNX
13
SCYX
11
SGEN
9
SNY
87
SNYNF
63
SRNE
19
TAK
12
TAYD
17
TEVJF
11
VERU
10
Exchanges
Amex
75
Lse
12
Nasdaq
2205
Nyse
493
Tsx
38
Crawled Date
2023 - 09 - 26
10
2023 - 09 - 07
8
2023 - 07 - 17
12
2023 - 06 - 05
14
2023 - 05 - 25
10
2023 - 05 - 16
11
2023 - 05 - 09
9
2023 - 04 - 26
10
2023 - 04 - 17
9
2023 - 03 - 28
8
2023 - 02 - 16
8
2022 - 12 - 12
8
2022 - 11 - 03
10
2022 - 09 - 16
9
2022 - 07 - 28
8
2022 - 06 - 22
10
2022 - 06 - 10
9
2022 - 05 - 23
8
2022 - 04 - 25
8
2022 - 02 - 25
9
2022 - 02 - 14
10
2021 - 12 - 13
19
2021 - 12 - 09
15
2021 - 12 - 06
8
2021 - 11 - 30
8
2021 - 11 - 29
12
2021 - 11 - 15
9
2021 - 11 - 12
12
2021 - 11 - 08
8
2021 - 10 - 25
8
2021 - 10 - 15
9
2021 - 10 - 07
7
2021 - 10 - 04
8
2021 - 09 - 29
7
2021 - 09 - 28
7
2021 - 09 - 27
12
2021 - 09 - 20
13
2021 - 09 - 17
10
2021 - 09 - 16
9
2021 - 09 - 13
12
2021 - 08 - 18
7
2021 - 06 - 29
7
2021 - 06 - 28
8
2021 - 06 - 25
10
2021 - 06 - 22
7
2021 - 06 - 11
9
2021 - 06 - 07
8
2021 - 05 - 24
7
2021 - 05 - 21
15
2021 - 05 - 20
8
2021 - 05 - 19
7
2021 - 05 - 11
7
2021 - 04 - 20
7
2021 - 04 - 13
8
2021 - 04 - 12
7
2021 - 03 - 24
9
2021 - 03 - 15
7
2020 - 12 - 11
9
2020 - 12 - 09
8
2020 - 12 - 01
12
Crawled Time
00:00
44
00:20
7
01:00
24
02:00
13
03:00
7
04:00
6
04:20
2
05:00
15
06:00
27
07:00
40
08:00
41
08:20
5
09:00
30
10:00
34
11:00
172
11:01
3
11:03
2
12:00
388
12:01
5
12:03
8
12:04
2
12:07
3
12:15
42
12:20
100
12:30
38
12:58
2
13:00
263
13:01
6
13:02
3
13:04
2
13:05
2
13:07
2
13:14
2
13:15
32
13:20
67
13:30
39
14:00
179
14:01
11
14:15
21
14:20
35
14:30
19
15:00
118
15:15
7
15:20
14
15:30
16
16:00
56
16:01
3
16:20
32
17:00
85
18:00
65
19:00
42
20:00
78
20:20
16
21:00
98
21:06
5
22:00
97
22:01
3
22:12
3
22:13
5
23:00
72
Source
adnas.com
2
alzamend.com
2
americann.co
1
arcutis.com
1
beamforall.com
1
bridgebio.com
1
brightmindsbio.com
1
encoreenergycorp.com
1
feed.businesswire.com
1
hightideinc.com
1
iconicminerals.com
1
investor.aveooncology.com
1
investors.biomarin.com
1
investors.phiopharma.com
2
ir.akerotx.com
3
ir.anaptysbio.com
4
ir.auriniapharma.com
1
ir.benitec.com
2
ir.biolase.com
1
ir.biolinerx.com
2
ir.cyclerion.com
4
ir.hoththerapeutics.com
4
ir.kalvista.com
1
ir.opgen.com
1
ir.stockpr.com
2
ir.viveve.com
1
ir.vtvtherapeutics.com
2
ir.zynerba.com
1
mindmed.co
2
neurosense.investorroom.com
4
piedmontlithium.com
1
renovorx.com
2
revivapharma.com
1
sixthwave.com
1
spacfeed.com
9
www.4dpharmaplc.com
5
www.adnas.com
2
www.agtc.com
1
www.aquestive.com
7
www.avrupaminerals.com
2
www.beyondspringpharma.com
4
www.biospace.com
1054
www.cecorp.ca
2
www.cumulusmedia.com
2
www.curevac.com
2
www.cxxi.ca
3
www.eyenoviabio.com
2
www.globenewswire.com
980
www.hancockjaffe.com
2
www.hubspot.com
3
www.inventivapharma.com
2
www.izea.com
2
www.kindredbio.com
2
www.lomiko.com
2
www.pensaregrp.com
2
www.prnewswire.com
416
www.rangerenergy.com
6
www.taylordevices.com
17
www.vbivaccines.com
3
www.vynetherapeutics.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Positive
save search
TECPETROL URGES ALPHA LITHIUM SHAREHOLDERS TO TENDER AS SOON AS POSSIBLE, FOLLOWING POSITIVE RECOMMENDATION BY THE ALPHA BOARD OF DIRECTORS AHEAD OF BID DEADLINE OF 3 OCTOBER 2023
Published:
2023-09-29
(Crawled : 12:00)
- prnewswire.com
TX
|
News
|
$39.9
-0.25%
0.0%
170K
|
Non-Energy Minerals
|
-0.25%
|
O:
0.95%
H:
1.02%
C:
-1.19%
TS
|
News
|
$31.6
-1.47%
0.0%
1.6M
|
Non-Energy Minerals
|
-0.91%
|
O:
0.0%
H:
0.38%
C:
-0.91%
LTUM
|
News
|
$0.092
15.91%
85K
|
Mining, Quarrying, and Oil and ...
|
-7.61%
|
O:
0.0%
H:
0.0%
C:
-7.61%
lithium
positive
deadline
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
Published:
2023-09-29
(Crawled : 12:00)
- globenewswire.com
GPCR
|
News
|
$50.42
34.56%
25.68%
10M
|
n/a
|
37.99%
|
O:
78.13%
H:
0.65%
C:
-22.54%
gsbr-1290
agonist
positive
update
program
therapeutics
results
study
Capricor Therapeutics Announces Positive Type-B Meeting with the FDA to Discuss Pathway to BLA for CAP-1002 in Duchenne Muscular Dystrophy
Published:
2023-09-29
(Crawled : 12:00)
- globenewswire.com
CAPR
|
News
0 d
|
$3.415
-41.27%
-70.28%
2.7M
|
Health Technology
|
-43.09%
|
O:
-35.94%
H:
1.1%
C:
-11.17%
cap-1002
fda
positive
meeting
therapeutics
duchenne
Ascletis Announces Positive Interim Data from the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure
Published:
2023-09-29
(Crawled : 00:00)
- prnewswire.com
MS
|
News
3 d
|
$81.67
-0.63%
0.01%
6.8M
|
Finance
|
0.18%
|
O:
1.83%
H:
0.0%
C:
0.0%
asc22
hepatitis
cure
positive
expansion
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
Published:
2023-09-28
(Crawled : 13:00)
- globenewswire.com
VCEL
|
$33.57
-1.53%
-1.55%
400K
|
Health Technology
|
-5.63%
|
O:
0.73%
H:
0.59%
C:
-4.72%
MDWD
|
$10.89
0.18%
0.18%
18K
|
Health Technology
|
15.65%
|
O:
0.33%
H:
19.07%
C:
17.77%
nexobrid
positive
publication
results
study
Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility
Published:
2023-09-28
(Crawled : 12:00)
- globenewswire.com
ARDX
|
$4.08
0.99%
0.98%
4.8M
|
Health Technology
|
-1.09%
|
O:
0.61%
H:
0.96%
C:
-2.65%
positive
publication
tenapanor
trial
results
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
Published:
2023-09-28
(Crawled : 10:00)
- globenewswire.com
BNOX
|
$2.76
-18.1%
-22.1%
6.6M
|
n/a
|
174.11%
|
O:
480.71%
H:
12.06%
C:
-41.08%
bnc210
positive
topline
trial
results
Adverum Biotechnologies Announces Positive Aflibercept Protein Level Data from the LUNA Phase 2 Trial
Published:
2023-09-26
(Crawled : 20:00)
- globenewswire.com
ADVM
|
$1.49
-2.61%
-2.68%
210K
|
Health Technology
|
-12.79%
|
O:
0.0%
H:
1.74%
C:
-2.91%
positive
protein
trial
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
Published:
2023-09-26
(Crawled : 20:00)
- prnewswire.com
CRDF
|
$1.385
-3.15%
-3.25%
1.2M
|
Health Services
|
-14.2%
|
O:
17.9%
H:
4.97%
C:
-16.23%
lung
positive
onvansertib
cancer
pancreatic
cell
BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma
Published:
2023-09-26
(Crawled : 12:00)
- globenewswire.com
BFRG
|
$3.245
-4.84%
-5.08%
120K
|
n/a
|
13.59%
|
O:
8.71%
H:
37.18%
C:
13.78%
positive
treatment
preclinical
glioblastoma
study
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published:
2023-09-26
(Crawled : 12:00)
- globenewswire.com
ARVL
|
News
|
$1.15
0.0%
97K
|
Manufacturing
|
-2.07%
|
O:
-1.24%
H:
0.0%
C:
0.0%
PLRX
|
$17.35
5.79%
5.48%
890K
|
Health Technology
|
18.93%
|
O:
7.89%
H:
11.25%
C:
5.98%
liver
positive
fibrosis
bexotegrast
trial
therapeutics
Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
Published:
2023-09-26
(Crawled : 12:00)
- globenewswire.com
SLNO
1 d
|
$29.41
6.6%
6.19%
3M
|
Health Technology
|
563.15%
|
O:
371.91%
H:
44.29%
C:
27.62%
positive
therapeutics
results
study
Inozyme Pharma Announces Positive Interim Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE)
Published:
2023-09-26
(Crawled : 12:00)
- globenewswire.com
INZY
|
$4.205
-0.47%
-0.48%
600K
|
Health Technology
|
-2.55%
|
O:
-4.12%
H:
17.12%
C:
8.65%
inz-701
pharma
positive
ongoing
trials
Ionis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndrome
Published:
2023-09-26
(Crawled : 11:00)
- prnewswire.com
IONS
S
|
$45.35
-1.97%
-2.01%
1.3M
|
Health Technology
|
6.96%
|
O:
3.61%
H:
5.92%
C:
5.33%
positive
topline
results
study
Vigil Neuroscience Receives Positive Opinion from European Medicines Agency on Orphan Drug Designation for VGL101 for the Treatment of ALSP
Published:
2023-09-26
(Crawled : 11:00)
- globenewswire.com
VIGL
|
$5.48
-6.16%
-6.57%
20K
|
|
-12.07%
|
O:
-4.73%
H:
13.7%
C:
3.94%
vgl101
drug
positive
treatment
designation
Roivant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
Published:
2023-09-26
(Crawled : 10:00)
- globenewswire.com
ROIV
M
3 d
|
$11.7
-6.77%
-7.26%
17M
|
Manufacturing
|
17.15%
|
O:
18.36%
H:
8.73%
C:
5.17%
IMVT
3 d
|
$38.41
-3.47%
-3.59%
2.6M
|
Health Technology
|
91.57%
|
O:
61.13%
H:
29.2%
C:
23.75%
imvt-1402
positive
results
Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
Published:
2023-09-26
(Crawled : 10:00)
- globenewswire.com
IMVT
3 d
|
$38.41
-3.47%
-3.59%
2.6M
|
Health Technology
|
91.57%
|
O:
61.13%
H:
29.2%
C:
23.75%
imvt-1402
positive
results
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138Further Supports TTX-MC138 Application in Brain Cancer
Published:
2023-09-25
(Crawled : 17:00)
- biospace.com/
RNAZ
1 d
|
$0.5
-13.09%
-15.06%
4.8M
|
Professional, Scientific, and T...
|
-24.29%
|
O:
94.28%
H:
0.0%
C:
0.0%
mc138
ttx-mc138
pre-clinical
positive
cancer
application
therapeutics
results
glioblastoma
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138
Published:
2023-09-25
(Crawled : 13:00)
- globenewswire.com
RNAZ
1 d
|
$0.5
-13.09%
-15.06%
4.8M
|
Professional, Scientific, and T...
|
-24.29%
|
O:
94.28%
H:
0.0%
C:
0.0%
mc138
ttx-mc138
pre-clinical
positive
therapeutics
results
glioblastoma
Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023
Published:
2023-09-22
(Crawled : 21:00)
- globenewswire.com
MORF
|
$22.88
1.73%
1.7%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
morf-057
positive
← Previous
1
2
3
4
5
6
7
8
9
…
131
132
Next →
Gainers vs Losers
66%
34%
Top 10 Gainers
LVS
4
|
$45.84
0.64%
6.58%
4.6M
|
Consumer Services
MRDB
4
|
$0.43
-8.49%
4.65%
230K
|
n/a
CANO
|
News
|
$0.2536
-10.07%
4.42%
3.5M
|
Health Care and Social Assistan...
TUP
|
$1.4
-10.83%
4.29%
2.5M
|
Producer Manufacturing
KNW
4
|
$0.25
8.51%
4.0%
960K
|
Manufacturing
AULT
|
$0.3227
-19.38%
3.5%
3M
|
Manufacturing
RC
|
$10.11
-0.39%
3.16%
1.1M
|
Finance
GFI
|
$10.86
-0.27%
3.04%
3.8M
|
Non-Energy Minerals
VQS
|
$0.16
3.03%
1M
|
Information
ASXC
|
$0.27
-2.88%
2.85%
740K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.